Aortic Stenosis Market

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve.  Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global aortic stenosis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomédica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Aortic Stenosis Market Detailed Segmentation:

• By Type:
  • Congenital Aortic Stenosis
  •  Acquired Aortic Stenosis
• By Aortic Valve Types:
  • Mechanical Aortic Valves
  •  Bioprosthetic (Tissue) Aortic Valves
• By Severity:
  • Mild Aortic Stenosis
  • Moderate Aortic Stenosis
  • Severe Aortic Stenosis
• By End User:
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Company Profile:

• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• CryoLife, Inc.
• Braile Biomédica
• JenaValve Technology, Inc.
• Meril Life Sciences Pvt. Ltd.
• Micro Interventional Devices, Inc.
• gnite, Inc.